NR 341 PHARMACOLOGY
CLINICAL JUDGMENT EXAM (CJE)
2026/2027
Chamberlain University College of Nursing
Comprehensive Pharmacology Competency Assessment
Official Question Count: 25 Multiple-Choice & Scenario-Based Questions
Testing Time: 60 Minutes | Passing Score: 75–80% (19–20/25)
Format: Computer-Based, Proctored via Chamberlain University LMS
Aligned with NCSBN Clinical Judgment Measurement Model (CJMM)
Core Domains Assessed:
Pharmacokinetics & Pharmacodynamics
High-Alert Medications & Safety Protocols
Cardiovascular / Respiratory / Endocrine Pharmacology
Neuro/Psych Pharmacology
Anti-Infectives & Antimicrobial Stewardship
Pain Management & Palliative Pharmacology
Geriatric & Special Population Considerations
Scenario-Based Clinical Judgment Application
, Abstract
This document presents the NR 341 Pharmacology Clinical Judgment Exam (CJE) for the
2026/2027 academic cycle, comprising 25 multiple-choice and scenario-based questions aligned with the
standardized competency assessment administered by Chamberlain University College of Nursing. The
examination evaluates proficiency in pharmacological principles essential for safe, effective, and evidence-
based medication management in complex adult health settings. Core domains assessed include
pharmacokinetics and pharmacodynamics (half-life, therapeutic index, agonist-antagonist mechanisms,
first-pass effect), high-alert medication safety protocols (insulin, heparin, opioids, warfarin),
cardiovascular pharmacology (ACE inhibitors, ARNIs, beta-blockers), respiratory pharmacology
(bronchodilators, inhaled corticosteroids), endocrine pharmacology (antidiabetics, thyroid agents,
corticosteroids), neuro/psych pharmacology (SSRIs, antipsychotics, anticonvulsants), anti-infectives and
antimicrobial stewardship, pain management and palliative pharmacology, and geriatric and special
population considerations including Beers Criteria application and pediatric weight-based dosing. Each
question is accompanied by a detailed rationale grounded in current pharmacological evidence and
clinical practice guidelines, aligned with the NCSBN Clinical Judgment Measurement Model.
Keywords: NR 341; Pharmacology CJE; High-Alert Medications; Clinical Judgment; Pharmacokinetics;
Beers Criteria; Insulin Safety; Antimicrobial Stewardship
1. Introduction
The NR 341 Pharmacology Clinical Judgment Exam (CJE) represents the standardized
competency assessment used by Chamberlain University College of Nursing to evaluate nursing students'
proficiency in pharmacological principles essential for safe medication management. The 2026/2027
edition integrates the NCSBN Clinical Judgment Measurement Model (CJMM), emphasizing layered
clinical thinking: recognizing cues, analyzing cues, prioritizing hypotheses, generating solutions, taking
actions, and evaluating outcomes within pharmacotherapy contexts.
The examination consists of 25 questions distributed across critical pharmacology domains:
Pharmacokinetics and Pharmacodynamics (Q1–4), High-Alert Medications and Safety Protocols (Q5–8),
Cardiovascular Pharmacology (Q9–11), Respiratory Pharmacology (Q12–13), Endocrine Pharmacology
(Q14–16), Neuro/Psych Pharmacology (Q17–19), Anti-Infectives and Antimicrobial Stewardship (Q20–
21), Pain Management and Palliative Pharmacology (Q22–23), and Geriatric and Special Population
Considerations (Q24–25). Each question includes a detailed rationale providing evidence-based
justification, supporting both exam preparation and clinical competency development.
A passing score of 75–80% (19–20 correct answers) is typically required per Chamberlain nursing
program policy. This document provides all 25 questions with correct answers highlighted in bold green
and comprehensive rationales in italics, serving as both a study resource and practice examination tool.
2. Examination Instructions
• This examination contains 25 multiple-choice and scenario-based questions. Select the single best
answer.
• Total testing time is 60 minutes (approximately 2.4 minutes per question).
• Passing score is typically 75–80% (19–20/25 correct) per Chamberlain program policy.
• Domains: Pharmacokinetics (Q1–4), High-Alert Meds (Q5–8), Cardio (Q9–11), Respiratory (Q12–13),
Endocrine (Q14–16), Neuro/Psych (Q17–19), Anti-Infectives (Q20–21), Pain (Q22–23), Geriatric/Special
Pop (Q24–25).
• Correct answers are in bold green. Detailed rationales in italics follow each question.
• No external materials or electronic devices are permitted during the proctored examination.
CLINICAL JUDGMENT EXAM (CJE)
2026/2027
Chamberlain University College of Nursing
Comprehensive Pharmacology Competency Assessment
Official Question Count: 25 Multiple-Choice & Scenario-Based Questions
Testing Time: 60 Minutes | Passing Score: 75–80% (19–20/25)
Format: Computer-Based, Proctored via Chamberlain University LMS
Aligned with NCSBN Clinical Judgment Measurement Model (CJMM)
Core Domains Assessed:
Pharmacokinetics & Pharmacodynamics
High-Alert Medications & Safety Protocols
Cardiovascular / Respiratory / Endocrine Pharmacology
Neuro/Psych Pharmacology
Anti-Infectives & Antimicrobial Stewardship
Pain Management & Palliative Pharmacology
Geriatric & Special Population Considerations
Scenario-Based Clinical Judgment Application
, Abstract
This document presents the NR 341 Pharmacology Clinical Judgment Exam (CJE) for the
2026/2027 academic cycle, comprising 25 multiple-choice and scenario-based questions aligned with the
standardized competency assessment administered by Chamberlain University College of Nursing. The
examination evaluates proficiency in pharmacological principles essential for safe, effective, and evidence-
based medication management in complex adult health settings. Core domains assessed include
pharmacokinetics and pharmacodynamics (half-life, therapeutic index, agonist-antagonist mechanisms,
first-pass effect), high-alert medication safety protocols (insulin, heparin, opioids, warfarin),
cardiovascular pharmacology (ACE inhibitors, ARNIs, beta-blockers), respiratory pharmacology
(bronchodilators, inhaled corticosteroids), endocrine pharmacology (antidiabetics, thyroid agents,
corticosteroids), neuro/psych pharmacology (SSRIs, antipsychotics, anticonvulsants), anti-infectives and
antimicrobial stewardship, pain management and palliative pharmacology, and geriatric and special
population considerations including Beers Criteria application and pediatric weight-based dosing. Each
question is accompanied by a detailed rationale grounded in current pharmacological evidence and
clinical practice guidelines, aligned with the NCSBN Clinical Judgment Measurement Model.
Keywords: NR 341; Pharmacology CJE; High-Alert Medications; Clinical Judgment; Pharmacokinetics;
Beers Criteria; Insulin Safety; Antimicrobial Stewardship
1. Introduction
The NR 341 Pharmacology Clinical Judgment Exam (CJE) represents the standardized
competency assessment used by Chamberlain University College of Nursing to evaluate nursing students'
proficiency in pharmacological principles essential for safe medication management. The 2026/2027
edition integrates the NCSBN Clinical Judgment Measurement Model (CJMM), emphasizing layered
clinical thinking: recognizing cues, analyzing cues, prioritizing hypotheses, generating solutions, taking
actions, and evaluating outcomes within pharmacotherapy contexts.
The examination consists of 25 questions distributed across critical pharmacology domains:
Pharmacokinetics and Pharmacodynamics (Q1–4), High-Alert Medications and Safety Protocols (Q5–8),
Cardiovascular Pharmacology (Q9–11), Respiratory Pharmacology (Q12–13), Endocrine Pharmacology
(Q14–16), Neuro/Psych Pharmacology (Q17–19), Anti-Infectives and Antimicrobial Stewardship (Q20–
21), Pain Management and Palliative Pharmacology (Q22–23), and Geriatric and Special Population
Considerations (Q24–25). Each question includes a detailed rationale providing evidence-based
justification, supporting both exam preparation and clinical competency development.
A passing score of 75–80% (19–20 correct answers) is typically required per Chamberlain nursing
program policy. This document provides all 25 questions with correct answers highlighted in bold green
and comprehensive rationales in italics, serving as both a study resource and practice examination tool.
2. Examination Instructions
• This examination contains 25 multiple-choice and scenario-based questions. Select the single best
answer.
• Total testing time is 60 minutes (approximately 2.4 minutes per question).
• Passing score is typically 75–80% (19–20/25 correct) per Chamberlain program policy.
• Domains: Pharmacokinetics (Q1–4), High-Alert Meds (Q5–8), Cardio (Q9–11), Respiratory (Q12–13),
Endocrine (Q14–16), Neuro/Psych (Q17–19), Anti-Infectives (Q20–21), Pain (Q22–23), Geriatric/Special
Pop (Q24–25).
• Correct answers are in bold green. Detailed rationales in italics follow each question.
• No external materials or electronic devices are permitted during the proctored examination.
